v3.24.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss [Member]
Treasury Stock, Common
Series C Preferred Stock [Member]
Series C Preferred Stock [Member]
Retained Earnings [Member]
Series D Preferred Stock [Member]
Series D Preferred Stock [Member]
Retained Earnings [Member]
Preferred stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020     11,000                    
Common stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020       567,898,000                  
Stockholders' equity, balance at beginning of period at Dec. 31, 2020 $ 10,326   $ 1,056 $ 6 $ 4,257 $ 19,397   $ 45 $ (14,435)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 5,388         5,388              
Other comprehensive loss (139)             (139)          
Purchases of treasury stock (2,260)               (2,260)        
Common stock issued under employee benefit plans (in shares)       88,000                  
Common stock issued under employee benefit plans 9     $ 0 9                
Common stock issued and stock-based compensation expense (in shares)       845,000                  
Common stock issued and stock-based compensation expense 103     $ 0 103                
Dividends — common stock (569)         (569)              
Dividends — preferred stock                   $ (31) $ (31) $ (38) $ (38)
Preferred stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2021     11,000                    
Common stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2021       568,831,000                  
Stockholders' equity, balance at end of period at Dec. 31, 2021 12,789   $ 1,056 $ 6 4,369 24,147   (94) (16,695)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 4,316         4,316              
Other comprehensive loss (245)             (245)          
Purchases of treasury stock (2,359)               (2,359)        
Common stock issued under employee benefit plans (in shares)       107,000                  
Common stock issued under employee benefit plans 10     $ 0 10                
Common stock issued and stock-based compensation expense (in shares)       751,000                  
Common stock issued and stock-based compensation expense 89     $ 0 89                
Dividends — common stock $ (643)         (643)              
Dividends — preferred stock                   (31) (31) (31) (31)
Preferred stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2022 10,700   11,000                    
Common stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2022       569,689,000                  
Stockholders' equity, balance at end of period at Dec. 31, 2022 $ 13,895   $ 1,056 $ 6 4,468 27,758   (339) (19,054)        
Stockholders' equity, balance at end of period (Accounting Standards Update 2022-02 [Member]) at Dec. 31, 2022   $ 52         $ 52            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 955                        
Stockholders' equity, balance at end of period at Mar. 31, 2023 $ 13,598                        
Preferred stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022 10,700   11,000                    
Common stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022       569,689,000                  
Stockholders' equity, balance at beginning of period at Dec. 31, 2022 $ 13,895   $ 1,056 $ 6 4,468 27,758   (339) (19,054)        
Stockholders' equity, balance at beginning of period (Accounting Standards Update 2022-02 [Member]) at Dec. 31, 2022   52         52            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 1,844                        
Stockholders' equity, balance at end of period at Jun. 30, 2023 $ 13,382                        
Preferred stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022 10,700   11,000                    
Common stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022       569,689,000                  
Stockholders' equity, balance at beginning of period at Dec. 31, 2022 $ 13,895   $ 1,056 $ 6 4,468 27,758   (339) (19,054)        
Stockholders' equity, balance at beginning of period (Accounting Standards Update 2022-02 [Member]) at Dec. 31, 2022   52         52            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 2,430                        
Stockholders' equity, balance at end of period at Sep. 30, 2023 $ 13,665                        
Preferred stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022 10,700   11,000                    
Common stock, shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2022       569,689,000                  
Stockholders' equity, balance at beginning of period at Dec. 31, 2022 $ 13,895   $ 1,056 $ 6 4,468 27,758   (339) (19,054)        
Stockholders' equity, balance at beginning of period (Accounting Standards Update 2022-02 [Member]) at Dec. 31, 2022   $ 52         $ 52            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 2,796         2,796              
Other comprehensive loss 114             114          
Purchases of treasury stock (1,956)               (1,956)        
Common stock issued under employee benefit plans (in shares)       118,000                  
Common stock issued under employee benefit plans 11     $ 0 11                
Common stock issued and stock-based compensation expense (in shares)       1,031,000                  
Common stock issued and stock-based compensation expense 74     $ 0 74                
Dividends — common stock $ (689)         (689)              
Dividends — preferred stock                   $ (31) $ (31) $ (31) $ (31)
Preferred stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2023 10,700   11,000                    
Common stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2023       570,838,000                  
Stockholders' equity, balance at end of period at Dec. 31, 2023 $ 14,235   $ 1,056 $ 6 4,553 29,855   (225) (21,010)        
Stockholders' equity, balance at beginning of period at Mar. 31, 2023 13,598                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 889                        
Stockholders' equity, balance at end of period at Jun. 30, 2023 13,382                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 586                        
Stockholders' equity, balance at end of period at Sep. 30, 2023 13,665                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income $ 366                        
Preferred stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2023 10,700   11,000                    
Common stock, shares outstanding, balance at end of period (in shares) at Dec. 31, 2023       570,838,000                  
Stockholders' equity, balance at end of period at Dec. 31, 2023 $ 14,235   $ 1,056 $ 6 $ 4,553 $ 29,855   $ (225) $ (21,010)